News

Upcoming Investor Conferences for ORIC Pharmaceuticals Detailed

Upcoming Investor Conferences for ORIC Pharmaceuticals Detailed

ORIC Pharmaceuticals Engages with Investors in February

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) is a dedicated clinical-stage oncology company that focuses on innovative treatments aimed at overcoming the challenges posed by therapeutic resistance in cancer. This month, ORIC Pharmaceuticals will engage with investors at several notable conferences, showcasing its commitment to advancing cancer treatment and enhancing investor relations.

Investor Conference Participation

During February, ORIC Pharmaceuticals will participate in a series of investor events designed to discuss its latest advancements and initiatives in oncology. These events present an opportunity for management to connect with investors and convey the company’s vision for addressing drug resistance in cancer.

Jones Research Precision Medicine Day

The first event is the Jones Research Precision Medicine Day, where ORIC Pharmaceuticals management will take part in a fireside chat on a specified date. This session will discuss critical developments in precision medicine and how ORIC's innovative therapies fit into this evolving landscape.

Guggenheim Securities SMID Cap Biotech Conference

Next up is the Guggenheim Securities SMID Cap Biotech Conference. The company will participate in another insightful fireside chat. This forum aims to highlight emerging opportunities in the biotech sector for small and mid-cap companies, and ORIC intends to showcase its strategic approach and scientific advancements.

Oppenheimer 35th Annual Healthcare Life Sciences Conference

Lastly, ORIC will attend the Oppenheimer 35th Annual Healthcare Life Sciences Conference. Management will discuss their pioneering strategies and product pipelines that are aimed at enhancing patient outcomes in difficult-to-treat cancers.

Live Streaming and Replay Information

Investors interested in following the discussions can access the live webcasts through the investor section of ORIC Pharmaceuticals' website. Replays will be available for 90 days after the events, ensuring that stakeholders can stay informed about the company's developments.

Insight into ORIC Pharmaceuticals

Founded with a mission to tackle the issue of therapeutic resistance in cancer, ORIC Pharmaceuticals is dedicated to the advancement of new therapies. Their innovative pipeline includes key candidates such as ORIC-114, designed to combat specific cancer mutations, and ORIC-944, which targets the polycomb repressive complex 2 (PRC2) for prostate cancer treatment.

The Impact of their Candidates

ORIC-114 is noted for its effectiveness against EGFR and HER2 anomalies, while ORIC-944 focuses on prostate cancer by targeting genetic markers associated with the disease. The company strives to bring novel solutions to patients battling cancer, underlining their commitment to addressing major medical challenges.

Company Locations and Operations

With offices in South San Francisco and San Diego, California, ORIC Pharmaceuticals leverages a robust base for its research and development endeavors. The company is poised to shape the future of oncology therapy through its innovative approaches and strong investor engagement.

Frequently Asked Questions

What are the key investor conferences ORIC Pharmaceuticals is attending?

ORIC Pharmaceuticals will participate in the Jones Research Precision Medicine Day, Guggenheim Securities SMID Cap Biotech Conference, and Oppenheimer Healthcare Life Sciences Conference.

Where can I view the live webcasts of these conferences?

The live webcasts will be available through the investor section of ORIC Pharmaceuticals' website.

What does ORIC-114 target?

ORIC-114 selectively targets EGFR exon 20 and HER2 exon 20 mutations in various cancer types.

What is the focus of ORIC-944?

ORIC-944 is an allosteric inhibitor of the PRC2 complex aimed at treating prostate cancer.

How long will the replays of the webcasts be available?

Replays of the webcasts will be accessible for 90 days following each event.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 12

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 5

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
Omneky Integrates AI Growth Agent With Slack for Ads

Updated Category News Views 4

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 5

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading
WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 3

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 8

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 4

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading

Top 5 Most Recently Viewed Articles

Amber Grid Reports Strong Performance for 2024 Financial Year

Updated Category News Views 172

Overview of Amber Grid's Financial Performance in 2024 Amber Grid has recently published its financial results for the 2024 fiscal year, showcasing its performance during a challenging economic landscape. During the Ordinary General Meeting of Shareholders, the audited financial statements were approved, marking a significant step in the company's ongoing commitment to...

Continue Reading
Revolutionary Tech in Cancer Surgery Promises Better Outcomes

Updated Category News Views 76

Revolutionary Technology Enhancing Cancer Surgery In the realm of breast cancer treatment, the introduction of innovative tools has revolutionized the way surgical procedures are performed. Perimeter Medical Imaging AI, Inc. has announced groundbreaking results from a pivotal clinical trial studying its B-Series Optical Coherence Tomography (OCT) system combined with...

Continue Reading
US Markets React to Job Data: Broadcom's Disappointing Outlook

Updated Category News Views 163

US Stock Markets React to Job Market Data As stock trading opened, the results were mixed. Investors responded to the latest data from the Labor Department, which revealed that the US economy added fewer jobs in August than expected. This has led to increased speculation about the Federal Reserve's next move regarding interest rates, with some anticipating a more...

Continue Reading
Rathbones Group: Insights on Recent Position Disclosures

Updated Category News Views 122

Understanding Recent Disclosures by Rathbones Group Plc In the ever-evolving landscape of finance, disclosures play a pivotal role in maintaining transparency among market participants. One firm that has recently made headlines for its disclosures is Rathbones Group Plc, particularly in relation to their interests in Assura Plc. This article delves into the key...

Continue Reading
Crown Royal's New Push: Celebrating Genuine Connections

Updated Category News Views 12

A Toast to Connection: Crown Royal's Latest Endeavor Sometimes, a brand actually tunes into the drumbeat of everyday life. That's what Crown Royal's up to with their fresh platform "Bring It"—it's about more than just whiskey. It's about channeling those communal vibes that everyone craves these days. You see, they kicked this off with a honky tonk shindig in Los...

Continue Reading